The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arthritis

Merete Lund Hetland, K. Horslev-Petersen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Objective. Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study. Methods. 160 patients with early RA (
OriginalsprogEngelsk
TidsskriftClinical and Experimental Rheumatology
Vol/bind30
Udgave nummer4
Sider (fra-til)S44-S49
ISSN0392-856X
StatusUdgivet - 2012

Citationsformater